Sequenom (SQNM) Prelim FY12 Revs Come in Ahead of Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Sequenom (SQNM) Pressures into JPMorgan Presentation
January 9, 2013 12:21 PM ESTSequenom (Nasdaq: SQNM) shares are looking a little pressured on volume today heading into a presentation at the J.P. Morgan Healthcare Conference this morning.
Chairman and CEO Harry F. Hixson, Jr., Ph.D, and Ronald M. Lindsay, Ph.D., Director... More
Illumina (ILMN) Will Require 'Significant Investment' to Compete with Sequenom (SQNM)
January 7, 2013 9:45 AM ESTOn Monday morning, Sequenom (NASDAQ: SQNM) reported preliminary 2012 revenue that topped estimates. Despite this, shares traded lower. In related news, Illumina, Inc. (Nasdaq: ILMN) signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early... More
